These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30913451)

  • 1. IL-33 contributes to disease severity in Psoriasis-like models of mouse.
    Duan Y; Dong Y; Hu H; Wang Q; Guo S; Fu D; Song X; Kalvakolanu DV; Tian Z
    Cytokine; 2019 Jul; 119():159-167. PubMed ID: 30913451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
    Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
    Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
    Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
    Front Immunol; 2021; 12():635076. PubMed ID: 34025642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
    Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
    J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
    Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
    Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
    Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
    Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis.
    Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ
    Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Proinflammatory Cytokines and Imiquimod on GLUT1 in HaCaT Keratinocytes - a Potential Anti-Psoriatic Therapeutic Target?
    Makuch S; Kupczyk P; Makarec A; Chodaczek G; Ziółkowski P; Woźniak M
    Cell Physiol Biochem; 2023 Mar; 57(2):54-62. PubMed ID: 36945896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical anti-TNF-a ssDNA aptamer decreased the imiquimod induced psoriatic inflammation in BALB/c mice.
    Shobeiri SS; Dashti M; Pordel S; Rezaee M; Haghnavaz N; Moghadam M; Ansari B; Sankian M
    Cytokine; 2023 Dec; 172():156406. PubMed ID: 37879125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes.
    Wang A; Wei J; Lu C; Chen H; Zhong X; Lu Y; Li L; Huang H; Dai Z; Han L
    Int Immunopharmacol; 2019 Apr; 69():270-278. PubMed ID: 30743203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
    Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-33 alleviates psoriatic inflammation by suppressing the T helper type 17 immune response.
    Chen Z; Hu Y; Gong Y; Zhang X; Cui L; Chen R; Yu Y; Yu Q; Chen Y; Diao H; Chen J; Wang Y; Shi Y
    Immunology; 2020 Aug; 160(4):382-392. PubMed ID: 32306382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cang-ai volatile oil ameliorates imiquimod-induced psoriatic skin lesions by suppressing the ILC3s.
    Lin Y; Yin X; Ma S; Xue Y; Hu C; Xie Y; Zeng Y; Zhao X; Du C; Sun Y; Qu L; Xiong L; Huang F
    J Ethnopharmacol; 2024 May; 326():117867. PubMed ID: 38342155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
    Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
    J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice.
    Zhao K; Pu S; Sun L; Zhou D
    Int J Nanomedicine; 2023; 18():3781-3800. PubMed ID: 37457802
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Fujii K; Yamamoto Y; Mizutani Y; Saito K; Seishima M
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752186
    [No Abstract]   [Full Text] [Related]  

  • 18. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
    Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
    Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unconjugated bilirubin and its derivative ameliorate IMQ-induced psoriasis-like skin inflammation in mice by inhibiting MMP9 and MAPK pathway.
    Bharatha M; Nandana MB; Praveen R; Nayaka S; Velmurugan D; Vishwanath BS; Rajaiah R
    Int Immunopharmacol; 2024 Mar; 130():111679. PubMed ID: 38377853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
    Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
    Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.